home / stock / oncy / oncy news


ONCY News and Press, Oncolytics Biotech Inc. From 06/23/23

Stock Information

Company Name: Oncolytics Biotech Inc.
Stock Symbol: ONCY
Market: NASDAQ
Website: oncolyticsbiotech.com

Menu

ONCY ONCY Quote ONCY Short ONCY News ONCY Articles ONCY Message Board
Get ONCY Alerts

News, Short Squeeze, Breakout and More Instantly...

ONCY - Oncolytics up 54% in last three trading sessions

2023-06-23 12:53:42 ET Oncolytics Biotech ( NASDAQ: ONCY ) is up an impressive 54% since the market close on June 20. In early afternoon trading Friday, the stock is up 17% . The reason for the jump is that its oncologic pelareorep has been selected f...

ONCY - ONCY, METC and SIFY among mid-day movers

2023-06-22 13:21:19 ET Gainers: TRxADE HEALTH ( MEDS ) +56% . ShiftPixy ( PIXY ) +45% . Root ( ROOT ) +36% . VCI Global Limited ( VCIG ) +34% . Barfresh Food Group ( BRFH ) +27% . Oncolytics Biotech ( ONCY ) +23% . ...

ONCY - Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs

2023-06-22 10:30:47 ET Palm Beach, FL – June 22, 2023 – FinancialNewsMedia.com News Commentary – Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is ...

ONCY - Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial

Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial PR Newswire Adaptive clinical trial designed to accelerate registration pathways for pancreatic cancer therapies and expected to reduce cost of a Phase 3 study fo...

ONCY - New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

2023-06-08 12:15:22 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group –  By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle aga...

ONCY - Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer

2023-06-05 09:45:25 ET Palm Beach, FL – June 5, 2023 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has had a limited impact on the global breast cancer therapeutics market and reports see substantial growth now that it has receded. The sta...

ONCY - Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate

Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate Canada NewsWire Pelareorep-paclitaxel combination re...

ONCY - Catalyst Watch: Apple's WWDC event, OPEC fallout and REITs on display

2023-06-02 15:00:55 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

ONCY - Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

2023-05-31 10:45:37 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – May 31, 2023 – USA News Group –  With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days ...

ONCY - Oncolytics falls 16% after mid-stage data for breast cancer therapy

2023-05-26 14:01:57 ET Oncolytics Biotech ( NASDAQ: ONCY ) shed ~16% on Friday after announcing results from its Phase 2 trial for experimental therapy pelareorep as a combination regimen in patients with a certain type of breast cancer. Results shared ahead of a presentatio...

Previous 10 Next 10